Yokohama, Japan

Suguru Ohkawa

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Zeon Company, Ltd.. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suguru Ohkawa: Innovator in Thromboresistant Polyetherurethane Compounds

Introduction

Suguru Ohkawa is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of materials science, particularly in the development of thromboresistant compounds. His innovative work has implications for medical applications, enhancing the safety and effectiveness of various devices.

Latest Patents

Ohkawa holds a patent for "Thromboresistant polyetherurethane compounds and process for its." This patent describes a thromboresistant segmented polyetherurethane compound, which consists of a specific composition of polytetramethylene ether and polyalkylene ether segments. The unique formulation allows for improved performance in medical applications, particularly in devices that come into contact with blood.

Career Highlights

Suguru Ohkawa is associated with Nippon Zeon Company, Ltd., where he has been instrumental in advancing research and development in polymer materials. His expertise in polyetherurethane compounds has positioned him as a key figure in the industry, contributing to innovations that enhance product safety and efficacy.

Collaborations

Ohkawa has worked alongside talented colleagues such as Ryuichiro Yoda and Akira Fukutome. Their collaborative efforts have fostered an environment of innovation, leading to advancements in the field of thromboresistant materials.

Conclusion

Suguru Ohkawa's contributions to the development of thromboresistant polyetherurethane compounds highlight his role as an influential inventor in the materials science sector. His work continues to impact medical technology, paving the way for safer and more effective solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…